Clinical trials
Phase 2 Diabetes Mellitus, Type 1 trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 4 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 17 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Radboud University Medical Center | 2 |
| Throne Biotechnologies Inc. | 2 |
| Daniela Elleri | 1 |
| Karolinska University Hospital | 1 |
| Lorenzo Piemonti | 1 |
| Massachusetts General Hospital | 1 |
| McGill University Health Centre/Research Institute of the McGill University Health Centre | 1 |
| Medical University of Warsaw | 1 |
| National Center for Research Resources (NCRR) | 1 |
| Shanghai Jiao Tong University School of Medicine | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 1 | 17 |
| Diabetes Mellitus | 5 |
| Insulin Resistance | 3 |
| Autoimmune Diseases | 1 |
| Diabetes Mellitus, Type 2 | 1 |
| Disease Progression | 1 |
| Endocrine System Diseases | 1 |
| Glucose Metabolism Disorders | 1 |
| Inflammation | 1 |
| Metabolic Diseases | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.